应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
DGX 奎斯特诊疗
盘前交易 05-01 07:10:46 EDT
138.18
-1.32
-0.95%
最高
139.64
最低
137.23
成交量
106.75万
今开
138.80
昨收
139.50
日振幅
1.73%
总市值
153.51亿
流通市值
152.09亿
总股本
1.11亿
成交额
1.48亿
换手率
0.97%
流通股本
1.10亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
奎斯特诊疗盘中异动 快速上涨5.33%报141.41美元
自选股智能写手 · 04-29 22:28
奎斯特诊疗盘中异动 快速上涨5.33%报141.41美元
美国 FDA 发布实验室开发测试的最终规则
Reuters · 04-29 21:55
美国 FDA 发布实验室开发测试的最终规则
巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由138.00美元调整至144.00美元。
智通财经 · 04-26
巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由138.00美元调整至144.00美元。
奎斯特诊疗2024财年第一财季实现净利润1.93亿美元,同比减少3.98%
自选股智能写手 · 04-25
奎斯特诊疗2024财年第一财季实现净利润1.93亿美元,同比减少3.98%
黄仁勋亲自交付首台DGX H200系统 OpenAI最先受益
第一财经 · 04-25
黄仁勋亲自交付首台DGX H200系统 OpenAI最先受益
黄仁勋出镜,英伟达向OpenAI交付全球首台DGX H200产品
IT之家 · 04-25
黄仁勋出镜,英伟达向OpenAI交付全球首台DGX H200产品
OpenAI:接收英伟达交付的全球第一块DGX H200产品
华尔街见闻 · 04-25
OpenAI:接收英伟达交付的全球第一块DGX H200产品
奎斯特诊疗盘中异动 早盘快速拉升5.20%报136.86美元
自选股智能写手 · 04-23
奎斯特诊疗盘中异动 早盘快速拉升5.20%报136.86美元
Quest 诊断公司公布截至三月份的季度业绩 - 收益摘要
Reuters · 04-23
Quest 诊断公司公布截至三月份的季度业绩 - 收益摘要
需求强劲,Quest 诊断公司上调 2024 年利润和收入预期
Reuters · 04-23
需求强劲,Quest 诊断公司上调 2024 年利润和收入预期
Quest Diagnostics(DGX.US):2024年Q1财报实现营收23.66亿美元,前值
智通财经 · 04-23
Quest Diagnostics(DGX.US):2024年Q1财报实现营收23.66亿美元,前值
未来一天的看点--4 月 23 日星期二
Reuters · 04-23
未来一天的看点--4 月 23 日星期二
Quest Diagnostics Inc 预计每股收益1.86美元 - 财报前瞻
Reuters · 04-19
Quest Diagnostics Inc 预计每股收益1.86美元 - 财报前瞻
英伟达发布DGX SuperPOD引领AI超级计算新时代
IT 商业新闻网 · 03-20
英伟达发布DGX SuperPOD引领AI超级计算新时代
大摩谈液冷技术崛起:英伟达新DGX系统引领“散热革命”
华尔街见闻 · 03-12
大摩谈液冷技术崛起:英伟达新DGX系统引领“散热革命”
英伟达下一个DGX AI系统将采用液冷散热技术
IT 商业新闻网 · 03-12
英伟达下一个DGX AI系统将采用液冷散热技术
英伟达确认下一代DGX系统即将到来,将采用液冷散热
砍柴网 · 03-11
英伟达确认下一代DGX系统即将到来,将采用液冷散热
黄仁勋透露英伟达下一代 DGX AI 系统将采用液冷技术-36氪
新浪财经 · 03-11
黄仁勋透露英伟达下一代 DGX AI 系统将采用液冷技术-36氪
加载更多
公司概况
公司名称:
奎斯特诊疗
所属市场:
NYSE
上市日期:
--
主营业务:
奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。
发行价格:
--
{"stockData":{"symbol":"DGX","market":"US","secType":"STK","nameCN":"奎斯特诊疗","latestPrice":138.18,"timestamp":1714507200000,"preClose":139.5,"halted":0,"volume":1067479,"delay":0,"floatShares":110065165,"shares":111091574,"eps":7.431219,"marketStatus":"盘前交易","marketStatusCode":1,"change":-1.32,"latestTime":"05-01 07:10:46 EDT","open":138.8,"high":139.64,"low":137.23,"amount":148034966.75443,"amplitude":0.017276,"askPrice":141.37,"askSize":12,"bidPrice":135.1,"bidSize":7,"shortable":3,"etf":0,"ttmEps":7.431219,"exchange":"NYSE","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714570200000},"adr":0,"listingDate":850798800000,"adjPreClose":138.18,"adrRate":0,"dividendRate":0.020842,"postHourTrading":{"tag":"盘后","latestPrice":138.18,"preClose":138.18,"latestTime":"17:50 EDT","volume":68244,"amount":9429960.2046,"timestamp":1714513829181},"volumeRatio":0.6619643022385177},"requestUrl":"/m/hq/s/DGX/","defaultTab":"news","newsList":[{"id":"2431862296","title":"奎斯特诊疗盘中异动 快速上涨5.33%报141.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431862296","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431862296?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:28","pubTimestamp":1714400898,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时28分,奎斯特诊疗股票出现波动,股价急速上涨5.33%。截至发稿,该股报141.41美元/股,成交量35.0797万股,换手率0.32%,振幅4.74%。奎斯特诊疗股票所在的生命科学行业中,整体涨幅为0.57%。该信息摘要如下:巴克莱:维持Quest Diagnostics评级,由持股观望调整至持股观望评级, 目标价由138.00美元调整至144.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429222818861ea1c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429222818861ea1c7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431520869","title":"美国 FDA 发布实验室开发测试的最终规则","url":"https://stock-news.laohu8.com/highlight/detail?id=2431520869","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431520869?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:55","pubTimestamp":1714398935,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供,请见免责声明 )) 路透4月29日 - 美国食品和药物管理局(FDA) 周一公布了最终规则,以确保实验室开发的检测项目的安全性和有效性(LDTs),这些检测项目是在临床实验室内设计、制造和使用的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2430325337","title":"巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由138.00美元调整至144.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2430325337","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430325337?lang=zh_cn&edition=full","pubTime":"2024-04-26 02:45","pubTimestamp":1714070730,"startTime":"0","endTime":"0","summary":"巴克莱:维持Quest Diagnostics(DGX.US)评级,由持股观望调整至持股观望评级, 目标价由138.00美元调整至144.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042602453587b046ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042602453587b046ea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430280479","title":"奎斯特诊疗2024财年第一财季实现净利润1.93亿美元,同比减少3.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430280479","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430280479?lang=zh_cn&edition=full","pubTime":"2024-04-25 23:09","pubTimestamp":1714057772,"startTime":"0","endTime":"0","summary":"3月31日,奎斯特诊疗公布财报,公告显示公司2024财年第一财季净利润为1.93亿美元,同比减少3.98%;其中营业收入为23.66亿美元,同比增加1.50%,每股基本收益为1.74美元。从资产负债表来看,奎斯特诊疗总负债74.08亿美元,其中短期债务10.59亿美元,资产负债比为1.89,流动比率为0.97。机构评级:截至2024年3月31日,当前有16家机构对奎斯特诊疗目标价做出预测,其中目标均价为146.60美元,其中最低目标价为136.00美元,最高目标价为160.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523094287afc5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042523094287afc5d2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430344739","title":"黄仁勋亲自交付首台DGX H200系统 OpenAI最先受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2430344739","media":"第一财经","top":-1,"share":"https://www.laohu8.com/m/news/2430344739?lang=zh_cn&edition=full","pubTime":"2024-04-25 13:27","pubTimestamp":1714022876,"startTime":"0","endTime":"0","summary":"4月24日,英伟达首台超级AI芯片DGXH200系统交付,英伟达创始人CEO黄仁勋亲自送货上门,OpenAI成为首个用户。OpenAI总裁兼联合创始人格雷戈里·布罗克曼(GregBrockman)在X平台上发布了这一消息,并发出一张与黄仁勋及OpenAICEO奥尔特曼(SamAltman)的合影。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404253059138976.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404253059138976.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430416584","title":"黄仁勋出镜,英伟达向OpenAI交付全球首台DGX H200产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2430416584","media":"IT之家","top":-1,"share":"https://www.laohu8.com/m/news/2430416584?lang=zh_cn&edition=full","pubTime":"2024-04-25 08:32","pubTimestamp":1714005170,"startTime":"0","endTime":"0","summary":"IT之家 4 月 25 日消息,OpenAI 近日在旧金山举办了一场研讨会,英伟达首席执行官黄仁勋亲自出席,共同宣布交付第一台 Nvidia DGX H200,进一步表明 OpenAI 和英伟达公司之间的紧密合作。OpenAI 总裁兼联合创始人格雷格布罗克曼发布了一条推文,晒出了山姆阿尔特曼、黄仁勋以及布罗克曼的合影,而他们的前方是首台交付的 DGX H200。英伟达推出的 DGX H200 是高性能计算领域的重大进步,与前身 H100 相比,其性能大幅提升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8Z3vDxA90xG","is_publish_highlight":false,"gpt_icon":0},{"id":"2430499264","title":"OpenAI:接收英伟达交付的全球第一块DGX H200产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2430499264","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2430499264?lang=zh_cn&edition=full","pubTime":"2024-04-25 05:21","pubTimestamp":1713993698,"startTime":"0","endTime":"0","summary":"更多消息,持续更新中","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/517f6219-73e7-428a-bfca-e581480dd6ed.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/517f6219-73e7-428a-bfca-e581480dd6ed.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3713548","is_publish_highlight":false,"gpt_icon":0},{"id":"2429919030","title":"奎斯特诊疗盘中异动 早盘快速拉升5.20%报136.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429919030","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429919030?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:35","pubTimestamp":1713879324,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时35分,奎斯特诊疗股票出现波动,股价快速上涨5.20%。截至发稿,该股报136.86美元/股,成交量5.4442万股,换手率0.05%,振幅2.88%。奎斯特诊疗股票所在的生命科学行业中,整体涨幅为3.02%。其相关个股中,Neuronetics, Inc.、Prenetics Global、丹纳赫涨幅较大,T2 Biosystems, Inc.、Ispecimen Inc.、Applied Dna Sciences, Inc.较为活跃,换手率分别为1.29%、0.88%、0.42%,振幅较大的相关个股有Prenetics Global、Neuronetics, Inc.、Inotiv, Inc.,振幅分别为7.88%、6.68%、5.43%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321352487e82d22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042321352487e82d22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429197921","title":"Quest 诊断公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2429197921","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429197921?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879085,"startTime":"0","endTime":"0","summary":" * Quest Diagnostics Inc 公布的截至3月底的季度调整后每股收益为2.04美元,与去年同期持平。17位分析师对该季度的平均预期是每股收益1.86美元。华尔街预期为每股收益 1.82 美元至 1.90 美元。* Quest Diagnostics 公司公布的本季度每股收益为 1.72 美元。* 公司报告的季度净收入为 1.94 亿美元。* Quest Diagnostics Inc 本季度股价下跌了 2.3%,今年迄今为止下跌了 5.6%。* 医疗设施与服务同行的平均一致建议也是 \"买入\"。华尔街对 Quest Diagnostics Inc 的 12 个月目标价中位数为 142.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429195121","title":"需求强劲,Quest 诊断公司上调 2024 年利润和收入预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2429195121","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429195121?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:55","pubTimestamp":1713873306,"startTime":"0","endTime":"0","summary":" 路透社4月23日 - 实验室运营商 Quest Diagnostic周二上调了 2024 年的利润和收入预期,此前该公司第一季度的业绩超出预期,原因是市场对其诊断测试的需求强劲。Quest 公司提供一系列诊断测试,包括过敏、慢性病和癌症测试,该公司表示,在人工智能和自动化方面的投资帮助其提高了生产率。经调整后,该公司在截至 3 月 31 日的这一季度实现了每股 2.04 美元的利润,高于预期的每股 1.86 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429596193","title":"Quest Diagnostics(DGX.US):2024年Q1财报实现营收23.66亿美元,前值","url":"https://stock-news.laohu8.com/highlight/detail?id=2429596193","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429596193?lang=zh_cn&edition=full","pubTime":"2024-04-23 19:19","pubTimestamp":1713871190,"startTime":"0","endTime":"0","summary":"Quest Diagnostics(DGX.US):2024年Q1财报实现营收23.66亿美元,前值为23.31亿美元,预期值为22.9亿美元;每股收益为2.04美元,前值为2.04美元,预期值为1.85美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319272287a5f7a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042319272287a5f7a9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429977776","title":"未来一天的看点--4 月 23 日星期二","url":"https://stock-news.laohu8.com/highlight/detail?id=2429977776","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2429977776?lang=zh_cn&edition=full","pubTime":"2024-04-23 02:30","pubTimestamp":1713810600,"startTime":"0","endTime":"0","summary":"在第一季度交付量下降之后,收入下降将是近四年来的首次下降。制造业 PMI 初值预计为 52,上月为 51.9。另外,费城联邦储备银行将发布 4 月份非制造业商业前景调查报告。预计百事公司第一季度收入将有所增长,这主要得益于对其价格昂贵的苏打水和零食的稳定需求。由于红色金属价格上涨,铜业巨头 Freeport McMoRan 公司第一季度的盈利可能会大幅增长。保险公司 W R Berkley 将公布第一季度财报。由于消费者支出持续强劲,支付公司 Fiserv 第一季度利润预计将大幅增长。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428981651","title":"Quest Diagnostics Inc 预计每股收益1.86美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2428981651","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428981651?lang=zh_cn&edition=full","pubTime":"2024-04-19 21:13","pubTimestamp":1713532436,"startTime":"0","endTime":"0","summary":" * Quest Diagnostics Inc 将于4月23日公布截至2024年3月31日的财报,预计该公司的季度收入将出现下降。* LSEG 的分析师平均预期 Quest Diagnostics Inc 每股收益为 1.86 美元。该公司 2024 年 2 月 1 日发布的截至 3 月 31 日的每股收益指导值介于 1.81 美元和 1.87 美元之间。* 华尔街对 Quest Diagnostics Inc 的 12 个月目标价中位数为 142.50 美元,高于其上次收盘价 125.91 美元。4月19日 - 上一季度业绩。除非另有说明,所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420739818","title":"英伟达发布DGX SuperPOD引领AI超级计算新时代","url":"https://stock-news.laohu8.com/highlight/detail?id=2420739818","media":"IT 商业新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2420739818?lang=zh_cn&edition=full","pubTime":"2024-03-20 08:24","pubTimestamp":1710894259,"startTime":"0","endTime":"0","summary":"英伟达在举办的GTC开发者大会上,推出了DGX SuperPOD,这一创新性产品旨在处理万亿参数AI模型,为超大规模的生成式AI训...","market":"us","thumbnail":"http://www.itxinwen.com/uploadfile/2024/0320/thumb_205_0_20240320082444207.png","type":0,"news_type":0,"thumbnails":["http://www.itxinwen.com/uploadfile/2024/0320/thumb_205_0_20240320082444207.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.itxinwen.com/diannao/20240320/148057.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2418672306","title":"大摩谈液冷技术崛起:英伟达新DGX系统引领“散热革命”","url":"https://stock-news.laohu8.com/highlight/detail?id=2418672306","media":"华尔街见闻","top":-1,"share":"https://www.laohu8.com/m/news/2418672306?lang=zh_cn&edition=full","pubTime":"2024-03-12 15:48","pubTimestamp":1710229719,"startTime":"0","endTime":"0","summary":"黄仁勋预告新一代DGX系统将采用水冷散热,大摩称液冷解决方案的采用率有望随AI产业的进一步发展而提高。","market":"us","thumbnail":"https://wpimg-wscn.awtmt.com/4d5e608b-c3cf-4a5d-a0ec-91ecf9beba76.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/4d5e608b-c3cf-4a5d-a0ec-91ecf9beba76.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3710215","is_publish_highlight":false,"gpt_icon":0},{"id":"2418340832","title":"英伟达下一个DGX AI系统将采用液冷散热技术","url":"https://stock-news.laohu8.com/highlight/detail?id=2418340832","media":"IT 商业新闻网","top":-1,"share":"https://www.laohu8.com/m/news/2418340832?lang=zh_cn&edition=full","pubTime":"2024-03-12 09:19","pubTimestamp":1710206361,"startTime":"0","endTime":"0","summary":"黄仁勋确认:英伟达下一个DGX AI系统将采用液冷散热技术 英伟达CEO黄仁勋已经确认,英伟达下一个DGX AI系统将采用液...","market":"us","thumbnail":"http://www.itxinwen.com/uploadfile/2024/0312/thumb_205_0_20240312091945477.png","type":0,"news_type":0,"thumbnails":["http://www.itxinwen.com/uploadfile/2024/0312/thumb_205_0_20240312091945477.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.itxinwen.com/diannao/20240312/147304.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2418804288","title":"英伟达确认下一代DGX系统即将到来,将采用液冷散热","url":"https://stock-news.laohu8.com/highlight/detail?id=2418804288","media":"砍柴网","top":-1,"share":"https://www.laohu8.com/m/news/2418804288?lang=zh_cn&edition=full","pubTime":"2024-03-11 13:37","pubTimestamp":1710135455,"startTime":"0","endTime":"0","summary":"近日,英伟达创始人兼首席执行官黄仁勋在2024 SIEPR经济峰会上透露,英伟达下一款“即将到来”的设备将采用液冷散热。虽然没有明确具体是什么设备,但随着GTC 2024大会的临近,行业分析师普遍认为黄仁勋指的是用于人工智能的下一代DGX系统。目前不少大型数据中心服务器的CPU和GPU仍依赖风冷散热,包括当前一代的DGX系统。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111340168b22d565&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403111340168b22d565&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418824528","title":"黄仁勋透露英伟达下一代 DGX AI 系统将采用液冷技术-36氪","url":"https://stock-news.laohu8.com/highlight/detail?id=2418824528","media":"新浪财经","top":-1,"share":"https://www.laohu8.com/m/news/2418824528?lang=zh_cn&edition=full","pubTime":"2024-03-11 08:25","pubTimestamp":1710116703,"startTime":"0","endTime":"0","summary":"英伟达CEO黄仁勋已确认,其下一个DGX AI系统将采用液冷散热。这为数据中心领域带来了新的机遇。英伟达在一次会议上透露了该消息。数据中心和AI服务器领域一直在加快推进液冷步伐,各公司为液冷设备的制造工厂投入巨额资金。此外,液冷数据中心将需要大量的研发工作和足够的基础设施来维护。(新浪财经)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311082506876f9541&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311082506876f9541&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.questdiagnostics.com","stockEarnings":[{"period":"1week","weight":0.0108},{"period":"1month","weight":0.0381},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.0522},{"period":"1year","weight":-0.0093},{"period":"ytd","weight":0.0022}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"奎斯特诊疗公司于1990年在特拉华州成立。公司是全球领先的诊断信息服务提供商。公司在医疗生态系统中扮演着至关重要的角色,使人们能够采取行动改善健康状况。来自世界上最大的临床实验室结果数据库,其诊断见解揭示了识别和治疗疾病、激励健康行为和改善医疗管理的新途径。在正确的人和正确的背景下,它的诊断性见解可以激发改变生活的行动。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.011521},{"month":2,"riseRate":0.392857,"avgChangeRate":-0.004984},{"month":3,"riseRate":0.714286,"avgChangeRate":0.02465},{"month":4,"riseRate":0.678571,"avgChangeRate":0.071294},{"month":5,"riseRate":0.740741,"avgChangeRate":0.031727},{"month":6,"riseRate":0.666667,"avgChangeRate":0.02776},{"month":7,"riseRate":0.407407,"avgChangeRate":-0.009005},{"month":8,"riseRate":0.518519,"avgChangeRate":-0.010124},{"month":9,"riseRate":0.407407,"avgChangeRate":-0.007757},{"month":10,"riseRate":0.518519,"avgChangeRate":-0.000801},{"month":11,"riseRate":0.814815,"avgChangeRate":0.031525},{"month":12,"riseRate":0.740741,"avgChangeRate":0.030872}],"exchange":"NYSE","name":"奎斯特诊疗","nameEN":"Quest Diagnostics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奎斯特诊疗,DGX,奎斯特诊疗股票,奎斯特诊疗股票老虎,奎斯特诊疗股票老虎国际,奎斯特诊疗行情,奎斯特诊疗股票行情,奎斯特诊疗股价,奎斯特诊疗股市,奎斯特诊疗股票价格,奎斯特诊疗股票交易,奎斯特诊疗股票购买,奎斯特诊疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奎斯特诊疗(DGX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奎斯特诊疗(DGX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}